
Aims of LyRA
To build a network of:
-
People for knowledge sharing;
-
Registries through formal collaborations;
-
Datasets with streamlined mechanisms to enable collaborative research.
Our projects
We are conducting and collaborating with lymphoma experts on these projects.
LyRA White Paper
Strategic roadmap for the future of our alliance
Attributes & data mapping
Identifying similarities and differences between members for collaborations
Developing of clinical quality indicator set
Standardisation of evaluation tools to measure quality of care
Our steering committee
The multidisciplinary Steering Committee includes haematologists, medical oncologists, epidemiologists, biostatistician experienced in leading the well-established lymphoma registries, and patient advocates, from 11 countries.They provide program oversight of the establishment and governance of LyRA, and strategic direction of the future development to implement LyRA’s objectives.

Prof Eliza Hawkes, Chair
Monash University, Australia

Prof Martine Chamuleau
Amsterdam UMC, Netherlands

Prof Christopher Flowers
MD Anderson, United States

Prof Georg Heß
University of Mainz, Germany

Prof Susan Parsons
Tufts Medical Center, United States
Prof Karin Ekström Smedby
Karolinska Institutet, Sweden

Ms Lorna Warwick
Lymphoma Coalition

Prof Chan Cheah, Co-chair
Sir Charles Gairdner Hospital, Australia

Prof Andrew Evens
Rutgers Cancer Institute and Jack & Sheryl Morris Cancer Center, United States

Prof Tarec El-Galaly
Aarhus University, Denmark

A/Prof Matthew Maurer
Mayo Clinic, United States

Dr Astrid Pavlovsky
Fundación para Combatir la Leucemia, Argentina

Prof Marek Trněný
Charles University Hospital, Czech Republic

Ms Natacha Bolanos
Lymphoma Coalition

Prof James Cerhan
Mayo Clinic, United States

Prof Massimo Federico
Association Angela Serra for Cancer Research, Italy
Prof Hervé Ghesquieres
Claude Bernard Lyon 1 University, France

A/Prof Adam Olszewski
Brown University Health Cancer Institute, United States

A/Prof Michelle Poon
National University Cancer Institute, Singapore

A/Prof Diego Villa
BC Cancer, Canada

A/Prof Mark Bishton
University of Nottingham, England
